Retatrutide – 50mg (Research Peptide)

Molecular Formula: C₁₈₁H₂₈₈N₄₆O₅₄

Molecular Weight: ~4000 Da

Synonyms: LY-3437943, Triple Agonist Peptide

⸻

Overview

Retatrutide is a next-generation synthetic research peptide engineered as a triple receptor agonist targeting the GIP, GLP-1, and glucagon pathways.

This advanced multi-agonist profile makes it a highly sought-after compound for metabolic and energy regulation research, offering a unique approach to studying complex biochemical signaling systems.

⸻

Scientific Background

Retatrutide represents a new class of multi-pathway peptides designed to simultaneously engage key metabolic receptors.

In controlled research environments, triple agonist compounds have demonstrated the ability to influence glucose metabolism, lipid utilization, and cellular energy balance through coordinated receptor activity.

Its ability to activate multiple signaling pathways distinguishes it from traditional single or dual agonist peptides, making it an important tool in advanced metabolic and endocrinological research models.

⸻

Research Applications

    •    Multi-receptor agonist and incretin pathway studies

    •    Glucose metabolism and insulin signaling research

    •    Lipid metabolism and energy expenditure models

    •    Comparative analysis of dual vs. triple agonist peptides

⸻

Specifications

    •    Form: Lyophilized powder

    •    Purity: ≥98% (HPLC Verified)

    •    Storage: Store at –20 °C; protect from light and moisture

    •    Solubility: Soluble in sterile water or aqueous buffers

    •    Unit Size: 50mg vial

⸻

⚠️ Disclaimer

All products available on RH Peptides are intended strictly for laboratory research use only.

Not for human consumption, medical, or veterinary use.

Retatrutide is an investigational compound and is not approved by the FDA or any regulatory authority for therapeutic application.